Healthcare provider profile · identity verified

Madison E Zuis, FNP

Nurse Practitioner · QUEENSBURY, NY · NPI 1497135180

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Omeprazole	Omeprazole	346	83
Levothyroxine Sodium	Levothyroxine Sodium	294	61
Atorvastatin Calcium	Atorvastatin Calcium	259	75
Sertraline Hcl	Sertraline Hcl	207	40
Amlodipine Besylate	Amlodipine Besylate	196	53
Lisinopril	Lisinopril	189	52
Losartan Potassium	Losartan Potassium	175	39
Furosemide	Furosemide	174	43
Gabapentin	Gabapentin	163	36
Eliquis	Apixaban	151	29
Pantoprazole Sodium	Pantoprazole Sodium	144	30
Nystatin	Nystatin	138	41
Metoprolol Succinate	Metoprolol Succinate	134	45
Rosuvastatin Calcium	Rosuvastatin Calcium	123	29
Quetiapine Fumarate	Quetiapine Fumarate	121	22
Simvastatin	Simvastatin	111	25
Donepezil Hcl	Donepezil Hcl	106	20
Famotidine	Famotidine	91	21
Tramadol Hcl	Tramadol Hcl	91	23
Escitalopram Oxalate	Escitalopram Oxalate	84	28
Lorazepam	Lorazepam	84	26
Hydrochlorothiazide	Hydrochlorothiazide	83	26
Metformin Hcl	Metformin Hcl	82	17
Torsemide	Torsemide	82	15
Mirtazapine	Mirtazapine	81	14
Metoprolol Tartrate	Metoprolol Tartrate	76	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	75	28
Trazodone Hcl	Trazodone Hcl	75	18
Albuterol Sulfate Hfa	Albuterol Sulfate	69	30
Clonazepam	Clonazepam	62	14
Potassium Chloride	Potassium Chloride	60	13
Duloxetine Hcl	Duloxetine Hcl	59	12
Allopurinol	Allopurinol	56	12
Alendronate Sodium	Alendronate Sodium	55	18
Myrbetriq	Mirabegron	54	suppressed
Spironolactone	Spironolactone	54	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	53	36
Tamsulosin Hcl	Tamsulosin Hcl	53	16
Amiodarone Hcl	Amiodarone Hcl	49	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	46	43
Alprazolam	Alprazolam	44	25
Clopidogrel	Clopidogrel Bisulfate	43	16
Prednisone	Prednisone	43	34
Atenolol	Atenolol	41	suppressed
Finasteride	Finasteride	41	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	39	suppressed
Pravastatin Sodium	Pravastatin Sodium	38	11
Oxycodone Hcl	Oxycodone Hcl	37	suppressed
Carvedilol	Carvedilol	35	suppressed
Metformin Hcl Er	Metformin Hcl	35	suppressed
Memantine Hcl	Memantine Hcl	34	suppressed
Ranolazine Er	Ranolazine	34	suppressed
Synthroid	Levothyroxine Sodium	34	11
Bumetanide	Bumetanide	33	suppressed
Citalopram Hbr	Citalopram Hydrobromide	33	11
Ondansetron Hcl	Ondansetron Hcl	33	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	31	suppressed
Xarelto	Rivaroxaban	31	suppressed
Ezetimibe	Ezetimibe	30	suppressed
Midodrine Hcl	Midodrine Hcl	30	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Fluticasone Propionate	Fluticasone Propionate	29	14
Buspirone Hcl	Buspirone Hcl	28	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	28	suppressed
Jardiance	Empagliflozin	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Nifedipine Er	Nifedipine	27	suppressed
Cephalexin	Cephalexin	24	16
Diclofenac Sodium	Diclofenac Sodium	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Novolog Flexpen	Insulin Aspart	23	suppressed
Ozempic	Semaglutide	23	suppressed
Pregabalin	Pregabalin	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Entresto	Sacubitril/Valsartan	21	suppressed
Lansoprazole	Lansoprazole	20	suppressed
Nystop	Nystatin	20	suppressed
Sucralfate	Sucralfate	20	suppressed
Trulicity	Dulaglutide	20	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Irbesartan	Irbesartan	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Klor-Con 10	Potassium Chloride	19	suppressed
Montelukast Sodium	Montelukast Sodium	19	suppressed
Risperidone	Risperidone	19	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	19	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	18	suppressed
Fluconazole	Fluconazole	18	14
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Ipratropium Bromide	Ipratropium Bromide	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Amoxicillin	Amoxicillin	16	13
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Diazepam	Diazepam	15	suppressed
Lidocaine	Lidocaine	15	suppressed
Olanzapine	Olanzapine	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	14	suppressed
Breyna	Budesonide/Formoterol Fumarate	14	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Insulin Aspart Flexpen	Insulin Aspart	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	11
Celecoxib	Celecoxib	13	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Scopolamine	Scopolamine	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Varenicline Tartrate	Varenicline Tartrate	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Cevimeline Hcl	Cevimeline Hcl	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Lactulose	Lactulose	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Primidone	Primidone	12	suppressed
Selegiline Hcl	Selegiline Hcl	12	suppressed
Topiramate	Topiramate	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Nyamyc	Nystatin	11	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	11	11
Ramipril	Ramipril	11	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error